Globus Medical, Inc.
GMED
Classement en actions
#2036
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Prix de l'action
$75.80
Capitalisation boursière
$10.18B
Changement (1 jour)
-1.08%
Changement (1 an)
27.22%
Pays
US
Échange Globus Medical, Inc. (GMED)
Catégorie
Healthcare
Marge opérationnelle de Globus Medical, Inc. (GMED)
Marge opérationnelle au October 2026 TTM : 20.75%
Selon les derniers rapports financiers et le cours de l'action de Globus Medical, Inc., la marge opérationnelle actuelle (TTM) est de 20.75%. À la fin de 2023, elle était de 8.49%.
Historique de la marge opérationnelle pour Globus Medical, Inc. de 2009 à 2026
Marge opérationnelle à la fin de chaque année
| Année | Marge opérationnelle | Changez |
|---|---|---|
| 2026 (TTM) | 20.75% | 214.87% |
| 2024 | 6.59% | -22.38% |
| 2023 | 8.49% | -61.91% |
| 2022 | 22.29% | 24.18% |
| 2021 | 17.95% | 27.12% |
| 2020 | 14.12% | -35.53% |
| 2019 | 21.90% | -7.79% |
| 2018 | 23.75% | -6.68% |
| 2017 | 25.45% | -6.88% |
| 2016 | 27.33% | -13.54% |
| 2015 | 31.61% | 8.36% |
| 2014 | 29.17% | 24.66% |
| 2013 | 23.40% | -21.32% |
| 2012 | 29.74% | 1.26% |
| 2011 | 29.37% | -3.48% |
| 2010 | 30.43% | -5.50% |
| 2009 | 32.20% | 0.00% |
Marge opérationnelle pour des entreprises similaires ou concurrentes
| Entreprise | Marge opérationnelle | Différence de Marge Opérationnelle | Pays |
|---|---|---|---|
| 17.03% | -99.18% |
US
|
|
| 17.86% | -99.14% |
IE
|
|
| 22.03% | -98.94% |
US
|
|
| 21.46% | -98.97% |
US
|
|
| 0.00% | - |
DE
|
Qu'est-ce que la Marge opérationnelle d'une entreprise ?
La Marge opérationnelle est un indicateur clé pour évaluer la rentabilité d'une entreprise. Une marge d'exploitation plus élevée est généralement préférable car elle montre qu'une entreprise peut vendre ses produits ou services bien au-dessus de leurs coûts de production. Elle se calcule en divisant les bénéfices par le chiffre d'affaires.